Osteogenesis Imperfecta: Prospects for Molecular Therapeutics

This publication has 31 references indexed in Scilit:

• Use of the Cre/lox Recombination System to Develop a Non-lethal Knock-in Murine Model for Osteogenesis Imperfecta with an α1(I) G349C Substitution
  Journal of Biological Chemistry, 1999
• Ribozymes: Structure, Function and Potential Therapy for Dominant Genetic Disorders
  Annals of Medicine, 1996
• COLLAGENS: Molecular Biology, Diseases, and Potentials for Therapy
  Annual Review of Biochemistry, 1995
• Genetic counselling on brittle grounds: Recurring osteogenesis imperfecta due to parental mosaicism for a dominant mutation
  European Journal of Pediatrics, 1995
• Specific Inhibition of Expression of a Human Collagen Gene (COL1A1) with Modified Antisense Oligonucleotides. The Most Effective Target Sites are Clustered in Double-Stranded Regions of the Predicted Secondary Structure for the mRNA
  Biochemistry, 1994
• Evaluation of growth hormone axis and responsiveness to growth stimulation of short children with osteogenesis imperfecta
  American Journal of Medical Genetics, 1993
• Somatic cell mosaicism: Another source of phenotypic heterogeneity in nuclear families with osteogenesis imperfecta
  American Journal of Medical Genetics, 1993
• Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-α1(I) collagen gene
  Nature, 1988
• The molecular genetics of collagen
  BioEssays, 1985
• CLASSIFICATION OF OSTEOGENESIS IMPERFECTA BY DENTAL CHARACTERISTICS
  The Lancet, 1978